DaTscan FDA Approval History
FDA Approved: Yes (First approved January 14, 2011)
Brand name: DaTscan
Generic name: ioflupane I 123
Dosage form: Injection
Company: GE Healthcare
Treatment for: Diagnosis and Investigation
DaTscan (ioflupane I 123 injection) is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes (PS).
Development timeline for DaTscan
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
